Duloxetine in the management of diabetic peripheral neuropathic pain
Authors:
- Chad BoomershineCBChad Boomershine
- Beth A ScholzBSBeth A Scholz
Open Access
- 1 July 2011
- journal article
- Published by Taylor & Francis in Patient Preference and Adherence
- Vol. 5, 343-56
Abstract
Peer reviewed article authored by (Ormseth MJ, Scholz BA, Boomershine CS). Read article or submit your manuscript for publishing.Keywords
This publication has 63 references indexed in Scilit:
- Evidence‐based Guideline: Treatment of Painful Diabetic NeuropathyPM&R, 2011
- Treatment‐induced diabetic neuropathy: A reversible painful autonomic neuropathyAnnals of Neurology, 2010
- Standards of Medical Care in Diabetes—2010Diabetes Care, 2010
- Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic painBMC Neurology, 2009
- On the repeatability of brush-evoked allodynia using a novel semi-quantitative method in patients with peripheral neuropathic painPain, 2007
- Duloxetine versus Routine Care in the Long-Term Management of Diabetic Peripheral Neuropathic PainJournal of Palliative Medicine, 2006
- Diabetes, Hypertension, and Cardiovascular DiseaseHypertension, 2001
- Impact of sleep debt on metabolic and endocrine functionThe Lancet, 1999
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960